⚠ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All information presented is for educational and research reference purposes only.
⚠ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All information presented is for educational and research reference purposes only.
Triple-Action Metabolic Compound
GLP-3 (RT)
- LY3437943
- GLP-3
A 39-amino acid triple agonist peptide targeting GIP, GLP-1, and glucagon receptors, studied for metabolic regulation and body composition in clinical research. Premium Research Peptide.
$99.00
Fast Shipping
Free shipment protection
Overnight shipping available
Fast Shipping
Protected
Overnight Available
Free shipping
on orders over $150
Damage
protection
Secure checkout
256-bit SSL
USA Shipping
Free over $150
COA
Verified
Secure checkout
256-bit SSL
Certificate of Analysis
Third Party Tested
- LATEST
- ISO 17025
- 7x TESTING
99.90%
PURITY
- Passed full QC Panel
Variant
GLP-3 (RT) 10mg
Lot #
BL240513-01
Labeled
10mg
Actual
12.30mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.90%
Net Peptide Content
- 12.30mg
Identity (HPLC)
- Retatrutide
HPLC Conformity
Heavy Metals (ICP-MS)
- Not detected
Sterility (PCR)
- No growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.83%
PURITY
- Passed full QC Panel
Variant
Retatrutide 20mg
Lot #
BL240513-01
Labeled
20mg
Actual
23.47mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.83%
Net Peptide Content
- 23.47mg
Identity (HPLC)
- GLP RT
HPLC Conformity
Heavy Metals (ICP-MS)
- Not Detected
Sterility (PCR)
- No Growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
PURITY
- Passed full QC Panel
Variant
Retatrutide 30mg
Lot #
BL240513-01
Labeled
30mg
Actual
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
Net Peptide Content
Identity (HPLC)
HPLC Conformity
Heavy Metals (ICP-MS)
Sterility (PCR)
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.64%
PURITY
- Passed full QC Panel
Variant
Retatrutide 40mg
Lot #
BL240513-01
Labeled
40mg
Actual
39.04mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.64%
Net Peptide Content
- 39.04mg
Identity (HPLC)
- GLP RT
HPLC Conformity
Heavy Metals (ICP-MS)
- Not Detected
Sterility (PCR)
- No Growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.79%
PURITY
- Passed full QC Panel
Variant
Retatrutide 60mg
Lot #
BL240513-01
Labeled
60mg
Actual
63.33mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.79%
Net Peptide Content
- 63.33mg
Identity (HPLC)
- GLP RT
HPLC Conformity
Heavy Metals (ICP-MS)
- Not Detected
Sterility (PCR)
- No Growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.90%
PURITY
- Passed full QC Panel
Variant
GLP-3 (RT) 10mg
Lot #
BL240513-01
Labeled
10mg
Actual
12.30mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.90%
Net Peptide Content
- 12.30mg
Identity (HPLC)
- Retatrutide
HPLC Conformity
Heavy Metals (ICP-MS)
- Not detected
Sterility (PCR)
- No growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.83%
PURITY
- Passed full QC Panel
Variant
Retatrutide 20mg
Lot #
BL240513-01
Labeled
20mg
Actual
23.47mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.83%
Net Peptide Content
- 23.47mg
Identity (HPLC)
- GLP RT
HPLC Conformity
Heavy Metals (ICP-MS)
- Not Detected
Sterility (PCR)
- No Growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
PURITY
- Passed full QC Panel
Variant
Retatrutide 30mg
Lot #
BL240513-01
Labeled
30mg
Actual
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
Net Peptide Content
Identity (HPLC)
HPLC Conformity
Heavy Metals (ICP-MS)
Sterility (PCR)
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.64%
PURITY
- Passed full QC Panel
Variant
Retatrutide 40mg
Lot #
BL240513-01
Labeled
40mg
Actual
39.04mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.64%
Net Peptide Content
- 39.04mg
Identity (HPLC)
- GLP RT
HPLC Conformity
Heavy Metals (ICP-MS)
- Not Detected
Sterility (PCR)
- No Growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.79%
PURITY
- Passed full QC Panel
Variant
Retatrutide 60mg
Lot #
BL240513-01
Labeled
60mg
Actual
63.33mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.79%
Net Peptide Content
- 63.33mg
Identity (HPLC)
- GLP RT
HPLC Conformity
Heavy Metals (ICP-MS)
- Not Detected
Sterility (PCR)
- No Growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
compound information
Technical specifications
- Molecular Profile
GLP-3 (RT)
White to off-white lyophilized powder (cake).
type
Synthetic peptide
CAS Number
2381089-83-2
Molecular Weight
4,731 g/mol
Salt Form
Acetate
Molecular Formula
C₂₂₁H₃₄₂N₄₆O₆₈
Appearance
White to off-white lyophilized powder (cake).
- Storage Requirements
Stability Information
Handle with care to maintain potency
Lyophilized (powder)
-20°C • Long term
Short-term storage
2-8°C • ~30 days
Reconstituted
Protect from light / Keep refrigerated
Sources & References
Peer-reviewed research
- Obesity / triple hormone receptor agonist
Triple–Hormone-Receptor Agonist Retatrutide for Obesity
Year: 2023
PMID : 37366315
The New England Journal of Medicine
- Type 2 diabetes / GLP-3
GLP-3 for type 2 diabetes: a phase 2 randomized clinical trial
Year: 2014
PMID : 2023
The Lancet
- Obesity / GLP-1, GIP, glucagon receptor agonism
Glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, and glucagon receptor agonism for obesity
Year: 2023
PMID : 37366315
The New England Journal of Medicine
⚠
Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.